Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab Pilot in Squamous NSCLC
NCT00318136Phase 2Completed
- Sponsor
- Genentech
- Start
- Sep 2005
- Primary completion
- Jul 2009
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of bevacizumab in squamous cell carcinoma of the lung (SCCL), sponsored by Genentech. Started Sep 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
squamous cell carcinoma of the lung (SCCL)
Beyond the preview
Go deeper on NCT00318136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00318136.